- Home
- WALD vs CVRX Comparison
WALD vs CVRX Comparison
Compare WALD & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WALD | CVRX |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.7M | 171.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WALD | CVRX |
|---|---|---|
| Price | $1.51 | $7.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $4.30 | ★ $11.20 |
| AVG Volume (30 Days) | 49.7K | ★ 408.2K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | $3.03 | $16.78 |
| Revenue Next Year | $10.43 | $19.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $1.45 | $4.37 |
| 52 Week High | $3.45 | $13.34 |
Technical Indicators
Market Signals| Indicator | WALD | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 57.05 |
| Support Level | $1.48 | $6.76 |
| Resistance Level | $2.06 | $8.45 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 12.82 | 76.37 |
Price Performance
Historical ComparisonAbout WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.